Exagen (XGN) filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to 1.15 million shares by investor Perceptive Credit Holdings IV.
The shares relate to the exercise of a warrant certificate granted to the selling investor, Exagen said Friday in the filing.
The company won't receive proceeds from the sale of shares, and funds received from the exercise of the warrant certificate will be used for working capital and general corporate purposes.